A
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Agilent launches TapeStationDx systems for clinical NGS sample quality controlSep 21, 2026
- Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx in ovarian, fallopian tube, and primary peritoneal cancersJul 23, 2026
- Agilent received FDA approval for PD-L1 IHC 28-8 pharmDx across multiple gastrointestinal cancersJul 14, 2026
- Agilent received FDA approval for PD-L1 IHC 22C3 pharmDx in esophageal and gastroesophageal cancersMar 26, 2026
- Agilent received FDA approval for the PD-L1 IHC 22C3 pharmDx diagnostic in epithelial ovarian, fallopian tube, or primary peritoneal carcinomaFeb 11, 2026